Nimodipine

What is Nimodipine?

Nimodipine is a prescription medication that belongs to a drug class called calcium channel blockers, specifically a type known as a dihydropyridine. While calcium channel blockers as a group are often used for blood pressure, nimodipine is specifically approved to help improve neurological outcomes after a subarachnoid hemorrhage — a type of bleeding that occurs around the brain, most often caused by a ruptured brain aneurysm.

Nimodipine is used to help reduce the risk and severity of certain complications, particularly reduced blood flow to the brain, that can occur in the weeks following this type of bleeding event.

Nimodipine is available in the following oral formulations:

• Oral capsules (soft gelatin capsules)
• Oral liquid solution

Nimodipine is intended for oral use only (by mouth or through a feeding tube, if directed by a specialist). It is not given intravenously or by any injectable route.

What is the Recommended Dosage of Nimodipine?

Nimodipine dosing must be determined and closely supervised by a treating specialist, typically in a hospital setting following a subarachnoid hemorrhage. Dosage and treatment length depend on several factors, including:

• The timing of treatment relative to the hemorrhage
• The patient’s blood pressure and heart rate response during treatment
• Liver function, since dosing is often adjusted for patients with significant liver impairment
• Other medications the patient is taking, particularly those that affect the same liver enzyme pathways
• Age and overall clinical condition

Because nimodipine is generally started soon after a serious medical event and requires close monitoring of blood pressure and heart rate throughout treatment, dosing decisions must be made and supervised entirely by the treating medical team. Patients and caregivers should never adjust the dose or timing on their own.

Important safety warning: Nimodipine capsules must never be given intravenously or by any injectable route. Serious, life-threatening events, including death, have occurred when the contents of nimodipine capsules were injected instead of given by mouth. Nimodipine should only be administered exactly as prescribed — by mouth or via an enteral feeding tube if directed by a healthcare provider.

How Nimodipine Works

Nimodipine works by blocking calcium channels in the smooth muscle of blood vessels, which causes those vessels to relax. This mechanism gives it two properties relevant to its use:

• It helps relax and widen certain blood vessels, including those supplying the brain, which may help support blood flow following a subarachnoid hemorrhage
• Research suggests nimodipine has a neuroprotective effect on brain tissue that occurs somewhat independently of its blood-vessel-relaxing effects, though the exact reason for this benefit is not fully understood

Nimodipine is used to help reduce the risk and severity of delayed brain injury following subarachnoid hemorrhage. It does not reverse or treat the original bleeding event itself, and it is typically used for a defined, time-limited course as part of a broader hospital-based treatment plan.

Is a Prescription Required to Buy Nimodipine Online?

Yes. Nimodipine is a prescription-only medication and is not available over the counter. It is almost always started and closely monitored in a hospital setting following a subarachnoid hemorrhage, under the direct supervision of specialists such as:

• A neurologist or neurosurgeon
• An intensive care or critical care specialist

Because nimodipine is used in a serious, acute medical situation with close monitoring requirements, it is not appropriate for self-directed or unsupervised online purchase. If you are ever offered this medication without a prescription or outside of a supervised medical setting, this is a significant warning sign of a potentially counterfeit or unsafe product. Only obtain this medication through licensed pharmacies as directed by your treating medical team.

Side Effects of Nimodipine

Common Side Effects

Some side effects are relatively common and are often related to nimodipine’s blood-vessel-relaxing effects. These may include:

• Low blood pressure
• Headache
• Nausea
• Flushing (warmth or redness of the skin)
• Mild swelling in the hands or feet

Serious Side Effects

Less commonly, more serious side effects can occur and require prompt medical attention, including:

• Significant drops in blood pressure or changes in heart rate, which is why monitoring during treatment is essential
• Signs of liver problems, such as yellowing of the skin or eyes, dark urine, or unusual fatigue
• Signs of a bleeding problem, including unusual bruising or bleeding
• Signs of an allergic reaction, such as rash, swelling, or difficulty breathing
• Symptoms of increased pressure in the brain or new neurological changes

Because nimodipine is typically used in a hospital setting with continuous monitoring, most serious side effects are identified and managed promptly by the medical team. If you or a caregiver notice any new or worsening symptoms, alert the healthcare team immediately.

Drug Interactions

Nimodipine is processed by a liver enzyme system that is also involved in metabolizing many other medications, which makes it prone to certain interactions. Categories to be aware of include:

• Strong inhibitors of the CYP3A4 liver enzyme, including certain antibiotics and antifungal medications, which can significantly increase nimodipine levels and the risk of low blood pressure
• Strong inducers of the same enzyme system, which may reduce nimodipine’s effectiveness
• Other blood pressure–lowering medications, due to the potential for additive effects on blood pressure
• Over-the-counter (OTC) medications and antacids, some of which may affect how nimodipine is absorbed
• Herbal products and supplements, particularly those known to affect liver enzymes or blood pressure

Because nimodipine is generally administered in a hospital setting, the treating medical team will typically review the full medication list. Even so, patients and caregivers should ensure that all medications, supplements, and herbal products are disclosed to the care team.

Safety & Important Considerations

• Boxed warning: Nimodipine carries a serious safety warning regarding accidental intravenous or other injectable administration, which has caused death. Nimodipine must only be given by mouth or through an enteral feeding tube, exactly as directed.
• Liver disease: Patients with significant liver impairment may require dose adjustments and closer monitoring, since the liver plays a major role in processing this medication.
• Kidney function: Specific dosing guidance for kidney impairment is limited; the treating specialist will determine appropriate monitoring.
• Pregnancy and breastfeeding: Use during pregnancy should only occur if determined necessary by a treating specialist, as nimodipine may pose risks to a developing fetus. It is not known whether nimodipine passes into breast milk, so a healthcare provider should be consulted before breastfeeding during treatment.
• Blood pressure and heart rate monitoring: Close monitoring of blood pressure and heart rate is required throughout treatment, as nimodipine can cause clinically significant drops in blood pressure.
• Timing of treatment: Treatment is generally most effective when started within a specific window of time after the hemorrhage occurs, as determined by the treating medical team.

This medication should be used only for its approved purpose and under direct medical supervision. Off-label use should not be pursued without a treating specialist’s guidance.

Who This Medication Is For

Nimodipine is intended for adult patients who have experienced a subarachnoid hemorrhage caused by a ruptured intracranial (berry) aneurysm, regardless of the severity of their initial neurological condition. It is used specifically to help improve neurological outcomes following this event and is administered as part of a structured, time-limited course of treatment supervised by a specialist care team.

Who Should Not Take Nimodipine

You may not be a suitable candidate for this medication if you:

• Have a known allergy or hypersensitivity to nimodipine or other dihydropyridine calcium channel blockers
• Are taking certain strong CYP3A4 inhibitor medications where the interaction risk is considered too high
• Have a medical condition that your treating specialist determines makes this medication inappropriate or unsafe for you

This is not a complete list of contraindications. A licensed medical specialist will carefully review the patient’s full medical history and current medications before starting nimodipine.

What to Do If You Miss a Dose

Because nimodipine is typically administered in a hospital or closely supervised setting on a strict schedule, missed doses are managed directly by the treating medical team. If a dose is missed at home (for example, after transition to outpatient care, if applicable):

• Contact the treating medical specialist or pharmacist right away for specific guidance
• Do not take an extra or double dose to make up for a missed one
• Do not delay contacting your care team, since maintaining consistent blood levels may be important for effectiveness

Related medications to Nimodipine

Nimodipine has a specialized role following certain types of subarachnoid hemorrhage and should not be grouped as a routine blood-pressure medicine. Link primarily to a relevant Subarachnoid Hemorrhage or Cerebrovascular Medicines page rather than to Amlodipine or Nifedipine solely because they are calcium channel blockers.

Storage Instructions

• Store at room temperature, generally between 68°F and 77°F (20°C to 25°C)
• May be exposed briefly to temperatures between 59°F and 86°F (15°C to 30°C), such as during transport
• Store in a cool, dry place, tightly closed, and protected from light
• Do not refrigerate or freeze
• Keep out of reach of children and pets

Disclaimer:

This page is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Patients and caregivers must consult a licensed medical specialist — such as a neurologist, neurosurgeon, or critical care physician — before starting, changing, or stopping treatment with nimodipine. Treatment decisions must be based on a full clinical evaluation by a qualified specialist familiar with the patient’s individual medical history.